Item 2.02 Result of Operations and Financial Condition.
On
Certain financial information contained in Exhibit 99.1 is preliminary,
unaudited and subject to change or adjustment in connection with the completion
of the Company's quarter and year-end closing processes and the preparation of
its audited financial statements for the fiscal quarter and year ended
Item 7.01 Regulation FD Disclosure
On
The information contained in Items 2.02 and 7.01 (including Exhibits 99.1 and 99.2 attached hereto) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Forward-Looking Statements
This report and the exhibit attached hereto contain forward-looking statements
within the meaning of Section 27A of the Securities Act and Section 21E of the
Exchange Act. All statements other than statements of historical fact are
forward-looking statements. Forward-looking statements are based on management's
current assumptions and expectations of future events and trends, which affect
or may affect the Company's business, strategy, operations or financial
performance, and actual results and other events may differ materially from
those expressed or implied in such statements due to numerous risks and
uncertainties. Forward-looking statements include, but are not limited to,
statements about the Company's preliminary results of operations, including
fourth quarter and full year 2022 revenue and 2022 non-GAAP gross margin,
statements about possible or assumed future results of operations and financial
position, including expectations regarding projected revenues and non-GAAP gross
margin; statements regarding the Company's overall business strategy, plans and
objectives of management; the Company's expectations regarding the market sizes
and growth potential for Tablo and the total addressable market opportunities
for Tablo, the Company's planned expansion within the home hemodialysis market
and expected drivers of home dialysis adoption, as well as the Company's
expectations regarding the impact of macroeconomic factors on the Company, its
customers and suppliers Forward-looking statements are inherently subject to
risks and uncertainties, some of which cannot be predicted or quantified.
Factors that could cause actual results or other events to differ materially
from those contemplated in this press release can be found in the Risk Factors
section of the Company's public filings with the
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Number Description Press Release entitled "Outset Medical Reports Expected Fourth Quarter and Full Year 2022 Revenue, Provides 2023 Revenue and non-GAAP Gross 99.1 Margin Guidance" datedJanuary 9, 2023 99.2 Investor Presentation datedJanuary 2023 Cover Page Interactive Data File (embedded within the Inline XBRL 104 document)
--------------------------------------------------------------------------------
© Edgar Online, source